MoneyWorks4Me

Natco Pharma informs about outcome of board meeting

11 Feb 2016 Evaluate

Natco Pharma has informed that the Board of Directors of the Company at its meeting held on February 11, 2016, have taken on record the Interim CFO S V V N Appa Rao appointed as Chief Financial Officer of the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..